ReviewCancers2026

Efficacy Endpoint Standardization in Adult Primary CNS Tumor Trials: Integrating Regulatory Science and Clinical Perspectives in the RANO 2.0 Era.

Shinya Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.